I'm LongbridgeAI, I can summarize articles.The AI boom has officially moved to the hardware trenches. While software startups struggle to monetize, companies controlling advanced packaging, wafer-level testing, and critical rare earths are cashing massive checks in 2026.
Everyone is still hyperventilating over Nvidia and the latest AI models, but the real dirty work of the 2026 AI boom is happening in the trenches—the testing floors, the packaging plants, and the rare earth mines. We are seeing a massive infrastructure scramble, and the hardware players are happily cashing the checks while the software guys try to figure out how to pay for it all.
You want AI? You need chips. You want chips? You need packaging and raw materials. Amkor Technology (AMKR.US) is riding this wave so hard they had to double down on their Arizona advanced packaging facility, pushing the price tag to a staggering USD 12 billion in September. When customer demand breaks your Phase 1 plans before you even finish, you know you've got a tiger by the tail—especially with their Nvidia partnership padding the stats. Meanwhile, down in the dirt, MP Materials (MP.US) is playing the geopolitical long game. They’re swimming in US Department of Defense cash and riding a USD 3 billion critical minerals initiative. But the real drama? Rumors swirling this fall that a Chinese state-owned enterprise might backdoor its way into MP's cap table via Shenghe Resources. Tech sovereignty is a messy business.
Then you have the guys making sure these expensive chips don't fry. Aehr Test Systems (AEHR.US) is practically printing money from AI, which now makes up over 70% of their revenue, recently snagging a massive USD 22 million order just for AI processor wafer-level burn-in systems. Cohu (COHU.US) is pulling the same lever, hauling in multi-unit orders for next-gen AI data center processors and posting a massive 38% sales jump in Q2. But while the CEOs of Cohu and edge-AI chipmaker Ambarella (AMBA.US) were busy selling off shares this September (funny how that works when the market is hot), Ambarella is at least shipping product, dropping its new X7 AI accelerator to bring heavy compute to the edge.
The legacy analog giants are just doing what they do best: generating cash and buying growth. Texas Instruments (TXN.US) flexed its balance sheet in September, bumping its dividend for the 23rd straight year after a solid Q2 revenue beat. Analog Devices (ADI.US), brushing off a pesky summer data breach, is throwing its weight around by acquiring Alif Semiconductor to get deeper into AI-native processing. And then there’s 10x Genomics (TXG.US)—the odd duck out here in life sciences, but hardware nonetheless. They’re seeing crazy demand for their Atera spatial biology platform, upgrading their 2026 revenue guidance, and just swatted away a competitor in a patent suit.
The takeaway here is painfully simple. The AI hype cycle has moved past the initial shock and awe. Now, it's about the picks, the shovels, and the advanced packaging. If you're building the physical infrastructure, 2026 is your year.